Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Epitope-Specific IgE Profiles are Predictive of Desensitization and Remission in the IMPACT Trial.
Journal: The Journal of allergy and clinical immunology
Published: April 15, 2026
Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention.
Journal: NEJM evidence
Published: May 28, 2024
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment.
Journal: The Journal of allergy and clinical immunology
Published: November 07, 2022
Defining the window of opportunity and target populations to prevent peanut allergy.
Journal: The Journal of allergy and clinical immunology
Published: March 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Journal: Lancet (London, England)
Published: November 20, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
Journal: The Journal of allergy and clinical immunology
Published: June 14, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
Journal: The Journal of allergy and clinical immunology
Published: December 09, 2019
On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.
Journal: The Journal of allergy and clinical immunology
Published: November 26, 2019
Biomarkers of severity and threshold of allergic reactions during oral peanut challenges.
Journal: The Journal of allergy and clinical immunology
Published: September 20, 2019
A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol.
Journal: The Journal of allergy and clinical immunology
Published: June 11, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Journal: Lancet (London, England)
Published: April 05, 2019
The MALT1 locus and peanut avoidance in the risk for peanut allergy.
Journal: The Journal of allergy and clinical immunology
Published: December 04, 2018
Last Updated: 09/26/2026